George Morrow
Director/Board Member at ALIGN TECHNOLOGY, INC.
Net worth: 1 M $ as of 2024-03-30
Profile
George J.
Morrow is an Independent Director at Neurocrine Biosciences, Inc. since 2015 and at Align Technology, Inc. since 2006.
He previously served as the President, Chief Executive Officer & Director at Glaxo Wellcome, Inc. from 1993 to 2001.
He also held positions as an Independent Director at Safeway, Inc. from 2013 to 2015, at Vical, Inc. from 2012 to 2019, at Human Genome Sciences, Inc. in 2011, and at Otonomy, Inc. from 2015 to 2018.
Additionally, he served as a Director at Johns Hopkins Bloomberg School of Public Health, The Fuqua School of Business, and National Commerce Bank.
Mr. Morrow's former roles also include being the Executive VP-Global Commercial Operations at Amgen, Inc. from 2003 to 2011 and Vice President-Marketing at Merck & Co., Inc. from 1981 to 1992.
He holds a graduate degree from Bryn Mawr College, an undergraduate degree from Long Island University, and MBA degrees from The Fuqua School of Business and Duke University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ALIGN TECHNOLOGY, INC.
0.01% | 2023-05-29 | 4,387 ( 0.01% ) | 1 M $ | 2024-03-30 |
| 2024-03-13 | 0 ( -.--% ) | - $ | 2024-03-30 |
George Morrow active positions
| Companies | Position | Start |
|---|---|---|
| ALIGN TECHNOLOGY, INC. | Director/Board Member | 2006-01-31 |
| NEUROCRINE BIOSCIENCES, INC. | Director/Board Member | 2015-09-30 |
Former positions of George Morrow
| Companies | Position | End |
|---|---|---|
Vical, Inc.
 Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Director/Board Member | 2019-08-30 |
| OTONOMY | Director/Board Member | 2018-05-31 |
| SAFEWAY INC. | Director/Board Member | - |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Director/Board Member | - |
| AMGEN INC. | Corporate Officer/Principal | 2011-01-30 |
Training of George Morrow
| Duke University | Masters Business Admin |
| Bryn Mawr College | Graduate Degree |
| Long Island University | Undergraduate Degree |
| The Fuqua School of Business | Masters Business Admin |
| Southampton City College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| AMGEN INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| NEUROCRINE BIOSCIENCES, INC. | Health Technology |
| ALIGN TECHNOLOGY, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Safeway, Inc.
 Safeway, Inc. Food RetailRetail Trade Safeway, Inc. operates a chain of supermarkets. Its services include grocery delivery, gas reward points, pharmacy, deli, simple nutrition, gift cards, money services and floral and gift delivery. The company was founded by M. B. Skaggs in 1915 and is headquartered in Pleasanton, CA. | Retail Trade |
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Health Technology |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
| Glaxo Wellcome, Inc. | Health Technology |
Otonomy, Inc.
 Otonomy, Inc. BiotechnologyHealth Technology Otonomy, Inc. operates as a biopharmaceutical company. engages in the development of therapeutics for neurotology. The firm’s product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan on May 6, 2008 and is headquartered in San Diego, CA. | Health Technology |
| National Commerce Bank |
- Stock Market
- Insiders
- George Morrow
